Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L K Schluger

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|October 21, 1995
Tackling liver cancer with interferonL K Schluger, H Bodenheimer
The American Journal of Gastroenterology|November 1, 1994
Gastrointestinal hemorrhage from a Brunner's gland hamartomaL K Schluger, H Rotterdam, O Lebwohl
Clinical Transplantation|June 1, 1995
Viral hepatitis in liver transplant recipientsH C Bodenheimer, L K Schluger, P Sheiner
Hepatology (Baltimore, Md.)|February 1, 1995
Unexplained Budd-Chiari syndrome in a young manL K Schluger, O Cubukçu, F Klion, et al.
The Mount Sinai Journal of Medicine, New York|October 1, 1996
Isoniazid hepatotoxicity after orthotopic liver transplantationL K Schluger, P A Sheiner, M Jonas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2000
Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipientsS Emre, Y Genyk, L K Schluger, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 1997
Retransplantation for recurrent hepatitis CP A Sheiner, L K Schluger, S Emre, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantationP A Sheiner, M E Schwartz, E Mor, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantationL K Schluger, P A Sheiner, S N Thung, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantationP A Sheiner, P Boros, F M Klion, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|October 21, 1995
Tackling liver cancer with interferonL K Schluger, H Bodenheimer
The American Journal of Gastroenterology|November 1, 1994
Gastrointestinal hemorrhage from a Brunner's gland hamartomaL K Schluger, H Rotterdam, O Lebwohl
Clinical Transplantation|June 1, 1995
Viral hepatitis in liver transplant recipientsH C Bodenheimer, L K Schluger, P Sheiner
Hepatology (Baltimore, Md.)|February 1, 1995
Unexplained Budd-Chiari syndrome in a young manL K Schluger, O Cubukçu, F Klion, et al.
The Mount Sinai Journal of Medicine, New York|October 1, 1996
Isoniazid hepatotoxicity after orthotopic liver transplantationL K Schluger, P A Sheiner, M Jonas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2000
Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipientsS Emre, Y Genyk, L K Schluger, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 1997
Retransplantation for recurrent hepatitis CP A Sheiner, L K Schluger, S Emre, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantationP A Sheiner, M E Schwartz, E Mor, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantationL K Schluger, P A Sheiner, S N Thung, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantationP A Sheiner, P Boros, F M Klion, et al.
Pageof 1